4//SEC Filing
Brown Regina 4
Accession 0001641172-25-002299
CIK 0001335105other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 10:36 AM ET
Size
15.3 KB
Accession
0001641172-25-002299
Insider Transaction Report
Form 4
Brown Regina
Director
Transactions
- Award
Options to Purchase Common Stock
2025-03-31+9,508→ 9,508 totalExercise: $1.21From: 2025-03-31Exp: 2030-03-31→ Common (9,508 underlying)
Holdings
- 10,000
Options to Purchase Common Stock
Exercise: $5.88From: 2023-06-30Exp: 2028-06-30→ Common (10,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $30.30From: 2021-06-30Exp: 2026-06-30→ Common (10,000 underlying) - 6,269
Options to Purchase Common Stock
Exercise: $1.30From: 2024-09-30Exp: 2029-09-30→ Common (6,269 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (10,000 underlying) - 4,924
Options to Purchase Common Stock
Exercise: $2.33From: 2025-01-20Exp: 2030-01-20→ Common (4,924 underlying) - 4,904
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (4,904 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $7.45From: 2022-06-30Exp: 2027-06-30→ Common (10,000 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $28.00From: 2021-05-11Exp: 2026-05-11→ Common (25,000 underlying)
Footnotes (1)
- [F1]Effective March 31, 2025, the reporting person was granted stock options to purchase an aggregate of 9,508 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001862089
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 10:36 AM ET
- Size
- 15.3 KB